About Icon Genetics
Icon Genetics is a company based in Halle (Germany) founded in 1999 was acquired by Denka in August 2015.. Icon Genetics has raised $14.6 million across 2 funding rounds from investors including Denka, IBG Beteiligungsgesellschaft Sachsen-Anhalt and CFH. The company has 25 employees as of December 31, 2021. Icon Genetics offers products and services including magnICON® Platform and Recombinant Proteins. Icon Genetics operates in a competitive market with competitors including Core Biogenesis, Qkine, Future Fields, Protera and Algenex, among others.
- Headquarter Halle, Germany
- Employees 25 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Icon Genetics Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Icon Genetics
Icon Genetics offers a comprehensive portfolio of products and services, including magnICON® Platform and Recombinant Proteins. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for transient expression of recombinant proteins in plants.
Proteins for vaccines and diagnostics via plant-based production.
Funding Insights of Icon Genetics
Icon Genetics has successfully raised a total of $14.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.6 million completed in March 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $2.6M
-
First Round
First Round
(20 Jan 2000)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2002 | Amount | Series A - Icon Genetics | Valuation |
investors |
|
| Jan, 2000 | Amount | Series A - Icon Genetics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Icon Genetics
Icon Genetics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Denka, IBG Beteiligungsgesellschaft Sachsen-Anhalt and CFH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Equity partnerships are provided for startups and mid-sized companies in Saxony.
|
Founded Year | Domain | Location | |
|
Manufacturer of calcium carbide and chemical fertilizers
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Icon Genetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Icon Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Icon Genetics Comparisons
Competitors of Icon Genetics
Icon Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Core Biogenesis, Qkine, Future Fields, Protera and Algenex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
UBaaS platform for plant-based recombinant protein bioproduction is offered.
|
|
| domain | founded_year | HQ Location |
Animal-free growth factors are developed for life science applications.
|
|
| domain | founded_year | HQ Location |
Serum-free bioactive growth factors and recombinant proteins are biomanufactured.
|
|
| domain | founded_year | HQ Location |
Protein-based enzyme technologies are developed using deep learning algorithms.
|
|
| domain | founded_year | HQ Location |
Developer of recombinant biologics for animal and human health
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Icon Genetics
When was Icon Genetics founded?
Icon Genetics was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Where is Icon Genetics located?
Icon Genetics is headquartered in Halle, Germany. It is registered at Halle, Sachsen-anhalt, Germany.
Is Icon Genetics a funded company?
Icon Genetics is a funded company, having raised a total of $14.6M across 2 funding rounds to date. The company's 1st funding round was a Series A of $12M, raised on Jan 20, 2000.
How many employees does Icon Genetics have?
As of Dec 31, 2021, the latest employee count at Icon Genetics is 25.
What does Icon Genetics do?
Icon Genetics discovers and develops new biopharmaceuticals and high-value protein products using green plants as production hosts. They have developed new generation production platforms and product prototypes for pharmaceutical, animal health and chemical biotech markets. They offer new plant engineering technologies which address speed, yield, precision, expression control and safety of transgene management in plants. Its products include Transgene Operating Systems, a suite of technologies, including nuclear transformation of plants based on translational (promoterless), translation-fusion, and polycistronic vectors, as well as vectors that utilize vector assembly in planta or RNAprotein trans-splicing; plastid transformation that allows construction of transplastomic hosts for high-yield production of specialty proteins in chloroplasts; and pro-viral transfection of plants that provides advantages of fast amplification processes in a plant. The company also offers magnICON system for rapid genevector assembly and optimization, as well as for high yieldhigh throughput expression of genes in planta; lexICON system allows DNA bar-coding of genetically modified plants; and rubICON, a hybrid seed production and trait control system. In January 2006, the Company has been acquired by Bayer Innovation GmbH, a wholly owned subsidiary of Bayer AG. In January 2007,Icon Genetics AG has been merged into Icon Genetics GmbH. In January 2012, ICON has been acquired by Nomad Bioscience GmbH, Munich, Germany. In Aug 2015, the company was acquired by Japans Denka.
Who are the top competitors of Icon Genetics?
Icon Genetics's top competitors include Future Fields, Qkine and Oxford Expression Technologies.
What products or services does Icon Genetics offer?
Icon Genetics offers magnICON® Platform and Recombinant Proteins.